| Trial ID: | L3083 |
| Source ID: | NCT00274274
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir|DRUG: insulin aspart
|
| Outcome Measures: |
Primary: HbA1c, after 52 weeks | Secondary: Blood glucose profiles|Percentage of patients with HbA1c less than 7.0% after 52 weeks|Quality of Life|Frequency of BG measurements|Safety parameters|Duration of education
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
373
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-09
|
| Completion Date: |
2006-11
|
| Results First Posted: |
|
| Last Update Posted: |
2014-11-21
|
| Locations: |
Düsseldorf, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00274274
|
